Regulation 55 Amendment of Schedule 10 (national homoeopathic products)I1
United Kingdom
In paragraph 4(4)(a) of Schedule 10 (exceptions to requirement to submit safety data) insert “ UK ” before “marketing authorisation”.
Annotations
Commencement
- I1
Reg. 55 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1